Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses
- Robert G. Miller
- , Rongzhen Zhang
- , Paige M. Bracci
- , Ari Azhir
- , Richard Barohn
- , Richard Bedlack
- , Michael Benatar
- , James D. Berry
- , Merit Cudkowicz
- , Edward J. Kasarskis
- , Hiroshi Mitsumoto
- , Georgios Manousakis
- , David Walk
- , Bjorn Oskarsson
- , Jeremy Shefner
- , Michael S. McGrath
Producción científica: Article › revisión exhaustiva
33
Citas
(Scopus)